Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort

Modern Rheumatology

Volumn 21, Issue 6, 2011, Pages 608-620

  Yoshimura, Noriko ^a   Muraki, Shigeyuki ^a   Oka, Hiroyuki ^a   Kawaguchi, Hiroshi ^b   Nakamura, Kozo ^b   Akune, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biochemical markers of bone turnover; Bone formation; Bone mineral density; Bone resorption; Osteoporotic fracture

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE TURNOVER; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; SPINE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREDICTIVE VALUE OF TESTS;

EID: 84855708944     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0455-2     Document Type: Article

References (43)

1. Jornell O, Kanis JA, Oden A, Sembo I, Redlund-Johnell I, Petterson C, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15:38-42. (Pubitemid 38252438)
2. Muraki S, Yamamoto S, Ishibashi H, Nakamura K. Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab. 2006;24:100-4.
3. Yoshimura N, Muraki S, Oka H, Mabuchi A, En-yo Y, Yoshida M, et al. Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: The research on osteoarthritis/osteoporosis against disability (ROAD). J Bone Miner Metab. 2009;27:620-8.
4. Ministry of Health, Labour and Welfare. The outline of the results of National Livelihood Survey 2007. Available at: Http://www.mhlw.go.jp/toukei/ list/20-19-1.html Accessed 21st December 2010.
5. Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, et al. Fosamax Actonel Comparison Trial Investigators. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis. A randomized double-blind study. J Bone Miner Res. 2005;20:141-51. (Pubitemid 41716229)
6. Rizzoli R, Greenspan SL, Bone G 3rd, Schnitzer TJ, Watts NB, Adami S, et al. Alendronate Once-Weekly Study Group. Twoyear results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis J Bone Miner Res 2002;17:1988-96. (Pubitemid 35239200)
7. Shiraki M, Kushida K. Fukunaga M for the Alendronate Phase III Osteoporosis Research Group. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int. 1999;11: 183-92. (Pubitemid 29458712)
8. Morii H, Ohashi Y, Taketani Y, Fukunaga M, Nakamura T, Itabashi A, et al. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: Results from a randomized placebo-controlled trial. Osteoporos Int. 2003;14:793-800. (Pubitemid 37462128)
9. Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: The OFELY study. J Bone Miner Res. 1999;4:1614-21. (Pubitemid 29416689)
10. Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int. 1996;59: 328-33. (Pubitemid 26367078)
11. Bauer DC, Sklarin PM, Stone KL, Black DM, Nevitt MC, Ensrud KE, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women. The study of osteoporotic fractures. J Bone Miner Res. 1999;14:1404-10. (Pubitemid 29368303)
12. Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T, et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-Based Osteoporosis (JPOS) cohort study. Osteoporos Int. 1966;17:1086-95.
13. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res. 1996;11:1531-8. (Pubitemid 26331009)
14. Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: The OFELY prospective study. J Bone Miner Res. 2002;17:826-33. (Pubitemid 34441899)
15. Garnero P, Sornay-Rendu E, Claustrar B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fracture in postmenopausal women: The OFELY study. J Bone Miner Res. 2003;15:1526-36.
16. Yoshimura N, Hashimoto T, Kasamatsu T, Morioka S, Aoki N, Shiraki M. Bone metabolic marker levels in residents of a rural community in Japan. J Bone Miner Metab. 1996;14:39-42. (Pubitemid 126712738)
17. Yoshimura N, Hashimoto T, Sakata K, Morioka S, Kasamatsu T, Cooper C. Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck. The Taiji study. Calcif Tissue Int. 1999;65:198-202. (Pubitemid 29380338)
18. Kasamatsu T, Yoshimura N, Morioka S, Sugita K, Hashimoto T. A population survey on bone mineral density in a fishing village in Wakayama Prefecture (Part 1). Distribution of bone mineral density by sex and age on a representative sample of the community. Jpn J Hyg. 1996;50:1084-92. (in Japanese). (Pubitemid 26087841)
19. Yoshimura N, Kasamatsu T, Morioka S, Hashimoto T. A population survey on bone mineral density in a fishing village in Wakayama Prefecture (Part 2). The analysis of the risk factors affecting the bone mineral density. Jpn J Hyg. 1996;51:677-84. (in Japanese). (Pubitemid 26389188)
20. Yoshimura N, Hashimoto T, Morioka S, Sakata K, Kasamatsu T, Cooper C. Determinants of bone loss in a rural Japanese community. The Taiji study. Osteoporos Int. 1998;8:604-10. (Pubitemid 28566978)
21. Yoshimura N, Kakimoto T, Nishioka M, Kishi T, Iwasaki H, Niwa T, et al. Evaluation of reproducibility of bone mineral density measured by dual energy X-ray absorptiometry (DPX-L). J Wakayama Med Soc. 1997;48:461-6.
22. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843. Geneva: WHO; 1994.
23. Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, et al. Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis: Year 2000 revision. J Bone Miner Metab. 2001;19:331-7.
24. Kawaguchi H, Matsumoto T, Kurokawa T, Orimo H, Mizunashi K, Takuwa Y, et al. Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies (in Japanese). Clin Endocrinol. 1990;38:95-100.
25. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990;36:1328-32.
26. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, a crosslinking compound of collagen fibers, in human urine. J Biochem. 1983;94:1133-6. (Pubitemid 14227240)
27. Schmidt-Gayk H, Spanuth E, Kotting J, Bartl R, Felsenberg D, Pfeilshifter J, et al. Performance evaluation of automated assays for b-Crosslaps, N-MID osteocalcin and intact parathyroid hormone (BIROSE multicenter study). Clin Chem Lab Med. 2004;42:90-5. (Pubitemid 38401475)
28. Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, et al. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem. 1995;41:1560-6.
29. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem. 1996;42:947-54.
30. Hirota Y, Kurimoto F, Hata K, Miura M. Fundamental studies on the determination of serum intact PINP (amino-terminal propeptide of type I procollagen) with RIA method. Clin Endocrinol. 1997;4:431-5. (in Japanese).
31. Clemens JD, Herrick MV, Singer FR, Eyre DR. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem. 1997;43:2058-63. (Pubitemid 27497803)
32. Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S. Application of a new serum assay for type I collagen cross-linked N-telopeptides: Assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int. 1998;63:102-6. (Pubitemid 28347681)
33. Yoshimura N, Muraki S, Oka H, Mabuchi A, Kinoshita H, Yoshida M, et al. Epidemiology of lumbar osteoporosis and osteoarthritis and their causal relationship-is osteoarthritis a predictor for osteoporosis, or vice versa?: The Miyama study. Osteoporos Int. 2009;20:999-1008.
34. Yoshimura N, Hashimoto T. Differences of values of BMD between mountainous and fishing areas, Wakayama prefecture, Japan. Osteoporos Jpn. 1999;7:12-3. (in Japanese).
35. Yoshimura N, Sakata K, Morioka S, Yasuda Y, Hashimoto T, Kasamatsu T. The comparison of incidence of fast bone losers in mountainous and fishing areas. Osteoporos Jpn. 1997;5:231-4. (in Japanese).
36. Yoshimura N, Hashimoto T, Morioka S, Kasamatsu T, Aoki N, Shiraki M. The difference of distribution of bone metabolic marker levels between mountainous and fishing villages. Osteoporos Jpn. 1996;4:119-22. (in Japanese).
37. Wakayama Prefecture. The results of Nutrition Survey in Wakayama Prefecture 1993. (in Japanese).
38. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Cohort profile: Research on osteoarthritis/osteoporosisagainst disability (ROAD) study. Int J Epidemiol. 2010;39: 988-95.
39. Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C. The relationship between endogenous estrogen, sex hormone binding globulin and bone loss in female residents of a rural Japanese community: The Taiji study. J Bone Miner Metab. 2002;20:303-10. (Pubitemid 41184329)
40. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Capacity of endogenous sex steroids to predict bone loss, osteoporosis and osteoporotic fracture in Japanese men: Tenyear follow-up of the Taiji cohort study. J Bone Miner Metab 2011;29:96-102.
41. Yoshimura N, Takijiri T, Kinoshita H, Danjoh S, Kasamatsu T, Morioka S, et al. Characteristics and course of bone mineral densities among fast bone losers in a rural Japanese community: The Miyama study. Osteoporos Int. 2004;15:139-44. (Pubitemid 38252428)
42. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, for the Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis, Osteoporos Int 11 Suppl 2000;6:S2-17. (Pubitemid 32039509)
43. Seibel MJ. Molecular markers of bone turnover: Biochemical, technical and analytical aspects. Osteoporos Int. 2000;11(Suppl 6):S18-29. (Pubitemid 32039510)